-
Mashup Score: 0Limitations of Conventional Imaging for Assessing Renal Masses - 8 hour(s) ago
Experts on kidney cancer review challenges associated with limitations of conventional imaging for assessing renal masses and how to potentially improve sensitivity and specificity.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3Combination nivolumab/nab-paclitaxel shows efficacy in MIBC - 11 hour(s) ago
“[The] NURE-Combo trial provided insights into the potential value of expanding chemotherapy combinations with immune checkpoint [inhibitors] in muscle-invasive disease,” said Chiara Mercinelli, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2
Combination treatment with burst wave lithotripsy and ultrasonic propulsion for small, asymptomatic renal stones is feasible.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 12
“We found that approximately 2 out of every 3 patients with node-positive disease go on to some form of secondary treatment within 12 months,” says Daniel A. Triner, MD, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1Dosing begins in study of PSMA-targeted therapy in mCRPC - 1 day(s) ago
The phase 2/3 AlphaBreak trial is evaluating the safety and efficacy of FPI-2265 in patients with mCRPC who have been previously treated with 177Lu-PSMA radiotherapy.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 4Vobramitamab duocarmazine continues to show promise in mCRPC - 1 day(s) ago
“The interim safety and anti-tumor activity observed to date in the TAMARACK study look very promising for patients with metastatic castration-resistant prostate cancer,” said Johann de Bono, MD, MSc, PhD, FRCP, FMedSci.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3
“We’re doing a lot of active surveillance, and it’s good to know that most of these people are getting the appropriate care that they should receive,” says Yuzhi (Katherine) Wang, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3
“The results of the BRAVO study performed within the VA health care system showed significant decreases in the risk of recurrence and progression, as well as the potential for improved overall survival in patients who received a BLC compared to patients who received WLC only,” says Stephen B. Williams, MD, MBA, MS, FACS, FACHE.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1PUL yields superior patient experience over WVTT for BPH - 2 day(s) ago
Patients who received PUL experienced a greater reduction in inference regarding outdoor entertainment and community activities at 1 month vs WVTT.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
Experts discuss the limitations of conventional imaging in assessing renal masses. #kcsm #kidneycancer #urology https://t.co/m6Z98FatWV